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The sufficiency of Tax in cancer initiation is evident in a
variety of animal models, but the role Tax plays in can-
cer maintenance is less well understood. Tax is often
undetectable in freshly obtained ATLL cells and while
Tax promotes proliferation and protects cells from
apoptosis it is also highly immunogenic and cytotoxic.
We developed a mouse model in which Tax is expressed
in the Tet-On system in vivo. These mice carry 4 trans-
genes. Tax, under the TET-promoter (TET-TAX) was
provided by Warner Greene. The reverse tet activator,
coupled to the granzyme B promoter (GZB-rtTA) ,
drives Tax in activated T and NK cells in a doxycycline
(dox)-inducible manner. Two additional transgenes were
included for non-invasive imaging. TET-GFP, which is
regulated by the same promoter as Tax in this model,
serves as a readout for Tax gene expression and firefly
luciferase driven by the HTLV-1 LTR (LTR-LUC) serves
as a bioluminescent readout for Tax activity. Quadruple
transgenic mice were maintained with or without dox-
diet for 18 months. Over that time, 6 of 8 animals
receiving dox-diet developed marked lymphadenopathy
and splenomegaly, compared to 2 of 9 on normal diet. 1
of 9 mice lacking the GZB-rTA transgene and 0 of 7
mice lacking the TET-TAX trangene developed lym-
phoma. Discontinuation of dox after lymphadenopathy
resulted in a decrease in lymph node size and biolumi-
nescence, but remission was transient. This mouse
model allows us to regulate and detect Tax activity non-
invasively and will enable targeted interrogation of the
role of Tax in lymphoma.
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